Mitochondrial-derived peptide with AMPK-activating and insulin-sensitizing effects in animals. Athletic-performance claims are speculative — most work is in metabolic biology.
Best Peptides for Athletic Performance
Peptides associated with athletic performance contexts — ranked by evidence and WADA status.
Educational content only. This page is compiled from published research for reference and is not medical advice, diagnosis, or treatment. Readers should verify claims against primary sources and consult a qualified healthcare provider before making any health decisions. Full disclaimer.
Nearly every peptide discussed in the athletic space is either prohibited by WADA or has insufficient evidence to support performance claims. This page summarizes the landscape rather than endorsing use.
How we ranked: Ordered by: (1) mechanistic performance rationale, (2) human data, (3) WADA status. Not a recommendation.
GHRH analog. Raises GH and IGF-1. Prohibited by WADA. Human performance trials are absent.
Short-acting GHSR agonist. Stacked with CJC-1295 in performance protocols. Prohibited by WADA. No performance trials in athletes.
Thymosin beta-4 fragment. Recovery-focused. Prohibited by WADA. No controlled athletic-performance data.
Injury-recovery peptide. WADA prohibited. Athletic performance use relies on preclinical recovery data and anecdote, not controlled human outcomes.
Frequently Asked Questions
Which performance peptides are WADA banned?
Virtually all peptides in the performance space are either explicitly listed or covered by the WADA S0 Non-Approved Substances clause: BPC-157, TB-500, CJC-1295, ipamorelin, sermorelin, MK-677, and GH-class peptides are all prohibited in and out of competition.
Is any peptide allowed for athletes?
Athletes subject to WADA testing should assume all non-FDA-approved peptides carry anti-doping risk. Always check the current WADA Prohibited List before use.
Do peptides actually improve athletic performance?
No controlled human trial has demonstrated performance enhancement for any of the commonly cited "performance peptides." Anecdotal reports are not evidence.